Florencia Aliverti

Florencia Aliverti

Auto-generated profile, based on publicly available information

Florencia Aliverti

Universidad Nacional de La Plata, Facultad de Ciencias Veterinarias, La Plata, Argentina

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2026 in Journal of Dairy Science
Verified
Journal Article
Open access
VMVanina Laura Madoz
Vanina Laura Madoz
JBJudy Bettridge
Judy Bettridge
MLMariana F. Lucas
Mariana F. Lucas
FAFlorencia Aliverti
Florencia Aliverti
Nora MestorinoNora Mestorino
Nora Mestorino
Maria MarchettiMaria Marchetti
Maria Marchetti
To address the rising threat of antimicrobial resistance, many countries are making efforts to establish baseline data and monitor antimicrobial use (AMU) in livestock. Although international reporting uses the total mass of antimicrobial agents standardized by animal biomass, other metrics may be more useful for individual countries, farmers or veterinarians to monitor progress over time. Using garbage can audits, we collected observational data on on-farm AMU from a convenience sample of 29 Argentinian dairy farms, separated into adult and youngstock groups, and calculated mass- and course-based metrics to benchmark estimated usage over the first 365 d of collection. Aggregated data from all farms gave an overall average (mean) usage of 25.8 mg/PCU; when calculated per farm, median AMU was 19.37 mg/PCU (range 4.97 to 58.90 mg/PCU). The third-generation cephalosporin, ceftiofur, was widely used as an injectable in adult cattle, while enrofloxacin was commonly used in youngstock. Oral ciprofloxacin - marketed as part of a multivitamin preparation for use in newborn calves - while only found on 4 farms, constituted 34% of all Category B antimicrobials, recommended as restricted for use in livestock by the European Medicines Agency. Course-based metrics demonstrated that high medicine usage on individual farms tended to occur in only one of the following categories: Category B medicines, youngstock, intramammary or systemic treatment in adults. These granular metrics help identify problem areas for individual farms, but may be less useful for formulating policy and measuring progress. A reduction in Category B usage appears to be a good opportunity for improved stewardship for the majority of participants and potentially for similar intensifying farms in the Argentinian dairy sector, although country-specific data (such as actual course doses and lengths used in the country) would improve calculation methodology for national monitoring.

5 January 2026 in Exploration of Drug Science
Verified
Journal Article
Open access
PDF file
DBDaniel Buldain
Daniel Buldain
ABAndrea Buchamer
Andrea Buchamer
LCLihuel Gortari Castillo
Lihuel Gortari Castillo
KLKaren Julca Lozano
Karen Julca Lozano
FAFlorencia Aliverti
Florencia Aliverti
Maria MarchettiMaria Marchetti
Maria Marchetti
Aim: This study aimed to establish the in vitro efficacy of chlorhexidine (CHX)-silver nanoparticles (AgNP) based preparation, against Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (P. aeruginosa) in planktonic cultures, biofilms, and on inert stainless-steel surfaces. Methods: The in vitro antimicrobial activity of the CHX-AgNP formulation (Dermosedan MRSA Nano AG®) was evaluated against reference and multidrug-resistant (MDR) strains of S. aureus and P. aeruginosa by determining the minimum inhibitory and bactericidal concentrations (MIC and MBC), as well as the minimum biofilm inhibitory and eradication concentrations (MBIC and MBEC). Also, the residual bactericidal activity on inert stainless-steel surfaces was evaluated. Results: MIC against methicillin-resistant S. aureus (MRSA) and MDR P. aeruginosa (MDR-PA) isolates ranged between 5/2.5–20/10 µg/mL, up to 8,000 times lower than the manufacturer’s recommended concentration, while MBC ranged from 500 to 2,000 times lower. MBIC matched the MBC, while higher concentrations were needed to eradicate preformed biofilms. On stainless-steel surfaces, high antimicrobial activity was observed for both pathogens. No bacterial survival was detected even after 6 hours at 4% CHX + 2% AgNP concentration. The CHX-AgNP combination demonstrated strong antimicrobial and antibiofilm activity against both S. aureus and P. aeruginosa. Conclusions: These results support the potential application of Dermosedan MRSA Nano AG® as a strategy for managing topical resistant infections and for environmental disinfection in both veterinary and clinical settings.